A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer

The purpose of the study was to determine the maximum-tolerated dose (MTD) of oral capecitabine, combined with concurrent, standard preoperative pelvic radiotherapy, when given twice daily, from Monday to Friday throughout the course of radiotherapy, for locally advanced potentially resectable recta...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngan, S Y K, Michael, M, Mackay, J, McKendrick, J, Leong, T, Lim Joon, D, Zalcberg, J R
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Clinical
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747703/
https://www.ncbi.nlm.nih.gov/pubmed/15305186
http://dx.doi.org/10.1038/sj.bjc.6602106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747703/
https://www.ncbi.nlm.nih.gov/pubmed/15305186
http://dx.doi.org/10.1038/sj.bjc.6602106

Ejemplares similares